Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Altaire Pharmaceuticals, Inc.
FDA Inspection
•Altaire Pharmaceuticals, Inc.•March 19, 2012

Altaire Pharmaceuticals, Inc. – FDA Inspection, Mar 19, 2012

Record Details

This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on March 19, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Altaire Pharmaceuticals, Inc.
Inspection Date
March 19, 2012
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · f974de5b-1ab5-4777-99fc-699c1aff0b56

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
772796
FDA center
Human Drugs
Project area
Unapproved and Misbranded Drugs

FDA Citations

10
  1. 21 CFR 211.198(a)Quality Control Review
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.113(a)Procedures for non-sterile drug products
  4. 21 CFR 211.28(a)Protective Apparel Not Worn
  5. 21 CFR 211.130(a)Prevention of cross contamination, mix-ups
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.165(e)Test methods
  8. 21 CFR 211.166(a)(3)Valid stability test methods
  9. 21 CFR 211.80(a)Written Procedures Not Followed
  10. 21 CFR 111.325(a)Laboratory operations: electronic

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Altaire Pharmaceuticals, Inc.

13
DateClassificationOfficeProject area
April 21, 2026Not classifiedNew York District OfficeDrug Quality Assurance
October 21, 2024NAICenter for Devices and Radiological HealthCompliance: Devices
February 11, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 19, 2019OAICenter for Veterinary MedicineGeneric Drug Evaluation
March 9, 2017VAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
View all 13 other inspections on the company page
Other documents for Altaire Pharmaceuticals, Inc.
  • FDA Inspection 1314330 - 2026-04-21
  • FDA Inspection 1251507 - 2024-10-21
  • FDA Inspection 1162640 - 2022-02-11
  • FDA Inspection 1089315 - 2019-04-19
  • FDA Inspection 1005208 - 2017-03-09

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Altaire Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.